Clinical Trial Update: N-acetylcysteine to Reduce Ischemia/Reperfusion Injury in Liver Resection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether N-acetylcysteine reduces ischemia/reperfusion injury during liver resection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Hepatectomy, Reperfusion Injury | Phase 4 | Status: COMPLETED